Synthesis 2025; 57(20): 3022-3030
DOI: 10.1055/a-2661-3593
Paper

Stereocontrolled Synthesis of 2S,3R-(3)-Piperidinyl Glycine and 2S,4S-(3)-Piperidinyl Alanine: Medicinally Relevant Constrained Cyclic Amino Acids

Authors

  • Sofiane Hocine

    1   Department of Chemistry, Université de Montréal, Station Centre-Ville, C.P. 6128, Montreal, QC H3C 3J7, Canada (Ringgold ID: RIN5622)
  • Paul Skrzypczak

    1   Department of Chemistry, Université de Montréal, Station Centre-Ville, C.P. 6128, Montreal, QC H3C 3J7, Canada (Ringgold ID: RIN5622)
  • Victor Cosson

    1   Department of Chemistry, Université de Montréal, Station Centre-Ville, C.P. 6128, Montreal, QC H3C 3J7, Canada (Ringgold ID: RIN5622)
  • Nazim Boudjerada

    1   Department of Chemistry, Université de Montréal, Station Centre-Ville, C.P. 6128, Montreal, QC H3C 3J7, Canada (Ringgold ID: RIN5622)
  • Stephen Hanessian

    1   Department of Chemistry, Université de Montréal, Station Centre-Ville, C.P. 6128, Montreal, QC H3C 3J7, Canada (Ringgold ID: RIN5622)
    2   Department of Pharmaceutical Sciences, University of California, Irvine, California 92697, United States


Graphical Abstract

Dedication

Dedicated to Professor A. R. Chamberlin for his seminal contributions to synthetic organic and medicinal chemistry.

Abstract

The stereocontrolled syntheses of 2S,3R-(3)-piperidinyl glycine hydrochloride and 2S,4S-(3)-piperidinyl alanine hydrochloride are described. These conformationally constrained α,γ- and α,δ-diamino acids were obtained via the stereoselective allylation of N–Cbz aspartate and glutamate diesters, respectively, followed by the intramolecular cyclization to form the piperidine ring. Orthogonally protected intermediates enabled late-stage diversification. Final deprotections afforded the target amino acids in high yields. The combination of the natural α-amino acid fragment and the basic piperidine unit in 3-piperidinyl glycine and alanine reveals the embedded frameworks of l-ornithine and l-lysine, making them peripheral or inserted components within structures of bioactive compounds of value for drug optimization and development.



Publication History

Received: 02 June 2025

Accepted after revision: 15 July 2025

Article published online:
13 August 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany